by Richard Daverman, PhD
January 30, 2014 -- Mindray Medical has acquired a controlling stake in Shanghai Long Island Biotec through an equity transfer. Long Island makes thrombotic and hemostatic reagent products. Its R&D operation is located in New York, though all manufacturing is done in Shanghai’s Zhuanghang Park. Mindray’s IVD division produces hematology analyzers and reagents for both human and veterinary use. Mindray said the transaction would open a new growth area. Financial details were not disclosed. More details....
Stock Symbol: (NYSE: MR)
Help employers find you! Check out all the jobs and post your resume.
